1. Home
  2. STOK vs SEDG Comparison

STOK vs SEDG Comparison

Compare STOK & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • SEDG
  • Stock Information
  • Founded
  • STOK 2014
  • SEDG 2006
  • Country
  • STOK United States
  • SEDG Israel
  • Employees
  • STOK N/A
  • SEDG N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • SEDG Semiconductors
  • Sector
  • STOK Health Care
  • SEDG Technology
  • Exchange
  • STOK Nasdaq
  • SEDG Nasdaq
  • Market Cap
  • STOK 721.4M
  • SEDG 840.3M
  • IPO Year
  • STOK 2019
  • SEDG 2015
  • Fundamental
  • Price
  • STOK $9.36
  • SEDG $13.91
  • Analyst Decision
  • STOK Strong Buy
  • SEDG Hold
  • Analyst Count
  • STOK 8
  • SEDG 26
  • Target Price
  • STOK $21.83
  • SEDG $25.95
  • AVG Volume (30 Days)
  • STOK 933.4K
  • SEDG 4.7M
  • Earning Date
  • STOK 11-05-2024
  • SEDG 02-18-2025
  • Dividend Yield
  • STOK N/A
  • SEDG N/A
  • EPS Growth
  • STOK N/A
  • SEDG N/A
  • EPS
  • STOK N/A
  • SEDG N/A
  • Revenue
  • STOK $16,742,999.00
  • SEDG $1,046,751,000.00
  • Revenue This Year
  • STOK $105.42
  • SEDG N/A
  • Revenue Next Year
  • STOK N/A
  • SEDG $23.02
  • P/E Ratio
  • STOK N/A
  • SEDG N/A
  • Revenue Growth
  • STOK 81.08
  • SEDG N/A
  • 52 Week Low
  • STOK $4.09
  • SEDG $10.24
  • 52 Week High
  • STOK $17.58
  • SEDG $87.98
  • Technical
  • Relative Strength Index (RSI)
  • STOK 36.22
  • SEDG 46.56
  • Support Level
  • STOK $8.42
  • SEDG $13.48
  • Resistance Level
  • STOK $9.77
  • SEDG $15.62
  • Average True Range (ATR)
  • STOK 0.66
  • SEDG 1.27
  • MACD
  • STOK -0.09
  • SEDG -0.11
  • Stochastic Oscillator
  • STOK 28.40
  • SEDG 14.17

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About SEDG SolarEdge Technologies Inc.

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.

Share on Social Networks: